• Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Arg; Zygosity=Unspecified (from parent cell line).
  
• Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Lys401Arg; Zygosity=Unspecified (from parent cell line).
  

PubMed=25080943; DOI=10.1038/srep05924; PMCID=PMC4118152
Yukinari Kato, Mika Kato Kaneko;
A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.
Sci. Rep. 4:5924.1-5924.9(2014)

PubMed=26937552; DOI=10.1089/mab.2015.0077
Yukinari Kato, Satoshi Ogasawara, Hiroharu Oki, Ryusuke Honma, Michiaki Takagi, Yuki Fujii, Takuro Nakamura, Noriko Saidoh, Hazuki Kanno, Mitsuo Umetsu, Satoshi Kamata ...Show all 18 authors... , Hiroshi Kubo, Mitsuhiro Yamada, Yoshihiko Sawa, Kei-ichi Morita, Hiroyuki Harada, Hiroyoshi Suzuki, Mika Kato Kaneko; Show fewer authors
Novel monoclonal antibody LpMab-17 developed by CasMab technology distinguishes human podoplanin from monkey podoplanin.
Monoclon. Antib. Immunodiagn. Immunother. 35:109-116(2016)

PubMed=27328060; DOI=10.1089/mab.2016.0006
Satoshi Ogasawara, Mika Kato Kaneko, Ryusuke Honma, Hiroharu Oki, Yuki Fujii, Michiaki Takagi, Hiroyoshi Suzuki, Yukinari Kato;
Establishment of mouse monoclonal antibody LpMab-13 against human podoplanin.
Monoclon. Antib. Immunodiagn. Immunother. 35:155-162(2016)

Patent=US10227407
Yukinari Kato, Mika Kato Kaneko;
Anti-podoplanin antibody.
Patent number US10227407, 12-Mar-2019